Skip to Content

S 063 (Agrylin 0.5 mg)

Generic Name: anagrelide

Pill with imprint S 063 is White, Capsule-shape and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc..

Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for S 063

Agrylin 0.5 mg S 063
Agrylin 0.5 mg S 063 Front
Agrylin 0.5 mg S 063 Back
Agrylin 0.5 mg S 063

Agrylin

Generic Name:
anagrelide
Imprint:
S 063
Strength:
0.5 mg
Color:
White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous coagulation modifiers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Shire US Inc.
Inactive Ingredients:
lactose anhydrous
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide